Publicaciones en las que colabora con Luis Castaño González (36)

2023

  1. Autoimmune Diabetes From Childhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype

    The Journal of clinical endocrinology and metabolism, Vol. 108, Núm. 11, pp. e1341-e1346

2020

  1. Incidence and regression of metabolic syndrome in a representative sample of the Spanish population: Results of the cohort di@bet.es study

    BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1

  2. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

    Scientific Reports, Vol. 10, Núm. 1

  3. Novel variant in the CNNM2 gene associated with dominant hypomagnesemia

    PLoS ONE, Vol. 15, Núm. 9 September

  4. Response to Letter to the Editor: "Forty-One Individuals with Mutations in the AVP-NPII Gene Associated with Familial Neurohypophyseal Diabetes Insipidus

    The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 7

2016

  1. El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinología española por la medicina individualizada y la investigación traslacional

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 6, pp. 274-284

2015

  1. Proyecto manejos integral en la DM tipo 1. Acuerdo en el manejo integral del paciente con diabetes mellit us tipo 1

    Avances en diabetología, Vol. 31, Núm. 1, pp. 13-23

  2. RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation

    European Journal of Endocrinology, Vol. 172, Núm. 3, pp. 301-307

2014

  1. Ambient temperature and prevalence of obesity in the spanish population: The di@bet.es study

    Obesity, Vol. 22, Núm. 11, pp. 2328-2332

  2. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clínica e investigación en arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  3. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  4. The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study

    Diabetes Technology and Therapeutics, Vol. 16, Núm. 7, pp. 435-441

  5. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955

2013

  1. Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863

  2. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1)

    Minerva Endocrinologica, Vol. 38, Núm. 1, pp. 17-28

  3. Endocrine profile and phenotype-(Epi)genotype correlation in Spanish patients with pseudohypoparathyroidism

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 5

  4. Factors affecting levels of urinary albumin excretion in the general population of Spain: The Di@bet.es study

    Clinical Science, Vol. 124, Núm. 4, pp. 269-277

  5. Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study

    European Journal of Clinical Investigation, Vol. 43, Núm. 1, pp. 1-10

  6. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study

    European Journal of Clinical Nutrition, Vol. 67, Núm. 9, pp. 911-916

  7. Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: The di@bet.es study

    Acta Diabetologica, Vol. 50, Núm. 4, pp. 615-623